Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Boragen Inc
Profile last edited on: 8/11/21      CAGE: 8FMD3      UEI: V9MSW4Y1ZGV5

Business Identifier: Leverageing unique characteristics of boron to address life science needs in crop protection and animal health
Year Founded
2015
First Award
2020
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

PO Box 110066 5 Laboratory Drive Suite 2
Durham, NC 27709
   (919) 607-4387
   info@boragenbio.com
   www.boragenbio.com
Location: Single
Congr. District: 04
County: Durham

Public Profile

Doing business in North Carolina but spun out of Pennsylvania State University in 2015 with the focus on expanding the boron platform to address unmet needs and challenges, Boragen was founded by a team of world-renowned chemists united through the study and formulation of boron as a springboard for unique application in the enhancement of human health. Boragen is developing a synthetic chemistry platform designed to leverage the unique characteristics of boron to address life science needs in crop protection and animal health. Currently the firm is organized around development of synthetic chemistry platforms designed to produce next-generation fungicides

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$300,500
Phase II Dollars
$299,639
Total Awarded
$600,139

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 2 NIH $1,552,939
Project Title: Benzoxaborole-Based Antimalarial Drug Discovery

Key People / Management

  Marissa Aubrey -- Senior Research Chemist/IP Analyst

  Stephen Benkovic -- Co-Founder

  Rich Gianni -- CFO

  Chris Hahne -- Crop Protection Scientist

  Sarah Jacobs -- Senior Scientist, Immunology

  Megan Mackowiak -- Program Manager

  Cari McGregor -- Research Associate

  Timothy Pastoor -- Senior Vice President VP

  Luke Steere -- Director of Crop Protection, Product Development

  Hannah Webb -- Business Development & Licensing

Company News

There are no news available.